Akoya Biosciences Inc (AKYA) Company Profile & Statistics

Akoya Biosciences Inc
AKYA
(Nasdaq - US)
N/A
2.78
-0.12 (-4.14%)
in:usd•As of: May 15, 2024 12:31 UTC -4
Open
2.85
High
2.91
Low
2.76

About Akoya Biosciences Inc

CEO

Brian McKelligon

Headquarters

100 campus drive, 6th floor

marlborough, ma 01762, united states

Auditor

RSM US LLP

Employees

330

Share Holders

Website

www.akoyabio.com

Industry

biotechnology

Sector

health technology

Company Overview

Akoya Biosciences Inc. offers comprehensive single-cell imaging solutions which allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. The company offer distinct solutions, the CODEX(R) and Phenoptics(TM) platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. Akoya Biosciences Inc. is based in MARLBOROUGH, Mass.

Akoya Biosciences Inc Statistics

Valuation Measures

Market Capitalization ²	137.28M
Enterprise Value	130.94M
Enterprise Value/EBITDA (ttm)	-2.68
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	3.76
Price to Sales (ttm)	2.17
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	58.06%
Operating Margin (ttm)	-65.82%
Profit Margin (ttm)	-67.07%
Return on Equity (ttm)	-98.47%
Return on Invested Capital (ttm)	-51.46%
Return on Assets (ttm)	-33.81%

Income Statement

Revenue (ttm)	96.63M
Revenue Per Share (ttm)	1.97
Gross Profit (ttm)	56.30M
EBITDA (ttm)³	-48.78M
Net Income Avi to Common (ttm)	-63.32M
Diluted EPS (ttm)	-1.47

Share Statistics

Beta (5Y Monthly)	1.52
52-Week Change	-52.07%
S&P500 52-Week Change	27.88%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	49.14M
Dividend Yield	0.00%
Float ⁴	45.77M
% Held by Insiders	7.30%
% Held by Institutions	79.42%

Balance Sheet

Total Cash (mrq)	83.13M
Total Cash Per Share (mrq)	1.69
Total Debt (mrq)	76.79M
Total Debt/Equity (mrq)	142.81%
Current Ratio (mrq)	3.45%
Quick Ratio (mrq)	2.94%
Book Value Per Share (mrq)	1.09

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.15
Free Cash Flow (ytd)	-54.55M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Akoya Biosciences Inc

Trade With A Regulated Broker